Welcome to our dedicated page for NeueHealth news (Ticker: BHG), a resource for investors and traders seeking the latest updates and insights on NeueHealth stock.
Bright Health Group, Inc. (BHG), operating under the banner of NeueHealth, Inc., aims to revolutionize the healthcare experience by fostering a more connected and intelligent approach to health services. The company offers affordable health insurance plans tailored to meet the needs of individuals. Bright Health collaborates with top-tier health systems to provide comprehensive and personalized healthcare solutions. Their user-friendly technology simplifies interactions between patients and healthcare providers, ensuring a seamless experience.
Bright Health's mission is encapsulated in their commitment to 'making healthcare right, together.' They achieve this by integrating innovative technologies with empathetic healthcare practices, thereby creating strong, meaningful connections between their members and care partners.
Currently, Bright Health's services are available in Colorado, with plans to expand to new geographic regions and introduce additional product offerings by 2018. Their approach leverages the expertise of brilliant minds and empathetic hearts to enhance patient outcomes and foster better health.
Recent achievements include exclusive partnerships with leading health systems, indicating a significant step towards reshaping the healthcare landscape. Financially, the company continues to show robust performance, driven by its strategic alliances and innovative healthcare solutions.
With a focus on providing up-to-date information, Bright Health remains dedicated to keeping its stakeholders informed about the latest developments and performance metrics. Their latest news and updates reflect the ongoing progress and milestones the company achieves in its journey to transform healthcare.
NeueHealth (NYSE: NEUE) reported Q3 2024 financial results, marking its third consecutive quarter of positive Adjusted EBITDA. Revenue reached $232.9 million in Q3 2024, down from $269.4 million in Q3 2023. The company reported a net loss of $40.4 million, significantly improved from a $547.1 million loss in Q3 2023. Value-Based Consumers served increased to 390,000 from 355,000 year-over-year. The company reaffirmed its 2024 guidance, expecting revenue of approximately $950 million and Adjusted EBITDA between $15-25 million.
NeueHealth (NYSE: NEUE) has announced the acquisition of the remaining 25% equity interest in Centrum Health, making it a wholly owned subsidiary. The transaction aims to simplify NeueHealth's corporate structure and streamline operations to support its value-driven, consumer-centric care model. According to CEO Mike Mikan, this move positions NeueHealth to create a more coordinated healthcare experience. Additional details about the transaction will be disclosed in an upcoming Form 8-K filing with the SEC.
NeueHealth, Inc. (NYSE: NEUE), a value-driven healthcare company, has announced its plans to report Third Quarter 2024 financial results on Thursday, November 7, 2024. The results will be released before the financial markets open, followed by a conference call at 8:00 AM Eastern Time.
Participants wishing to join the call via telephone must pre-register through a provided link. Upon registration, they will receive instructions on how to access the call, including dial-in details. Alternatively, a webcast of the earnings call will be available on NeueHealth's Investor Relations page at investors.neuehealth.com.
The company recommends participants dial in at least 15 minutes before the call starts. A recording of the earnings call and presentation will be made available on NeueHealth's Investor Relations page after the event concludes.
NeueHealth (NYSE: NEUE) reported solid Q2 2024 results, delivering positive Adjusted EBITDA for the second consecutive quarter. The company reaffirmed its full-year Adjusted EBITDA guidance and expects to reach the high end of its guidance range for consumers served by year-end. Key metrics include:
- Revenue: $225,991,000 (Q2 2024) vs $297,982,000 (Q2 2023)
- Net Loss: $57,698,000 (Q2 2024) vs $88,627,000 (Q2 2023)
- Adjusted EBITDA: $3,962,000 (Q2 2024) vs $7,797,000 (Q2 2023)
For 2024, NeueHealth projects:
- Revenue: ~$950 million
- NeueCare Revenue: ~$320 million
- NeueSolutions Revenue: ~$640 million
- Adjusted EBITDA: $15-25 million
The company continues to focus on advancing its value-driven model and delivering high-quality, consumer-centric care across ACA Marketplace, Medicare, and Medicaid populations.
NeueHealth, Inc. (NYSE: NEUE), a value-driven healthcare company, has announced its Second Quarter 2024 earnings conference call scheduled for August 7, 2024. The company will release its financial results before the markets open, followed by a conference call at 8:00 AM Eastern Time. Participants are encouraged to pre-register for the call and dial in at least 15 minutes early. A webcast of the earnings call will be accessible via NeueHealth's Investor Relations page, and a recording of the call and presentation will be available afterward on the same platform.
NeueHealth has secured a term loan facility for up to $150 million with Hercules Capital, significantly strengthening its balance sheet. This financing aims to advance NeueHealth's differentiated care model and support the company's strategic priorities in 2024 and beyond. The loan will help NeueHealth deliver value-driven, consumer-centric care across the ACA Marketplace, Medicare, and Medicaid. Both companies expressed optimism about the partnership's potential to drive value for payors, providers, and consumers.
NeueHealth announced it received a non-compliance letter from the NYSE on June 12, 2024. This notice states that the company failed to meet the continued listing standards due to its average market capitalization falling below $50 million over a 30 trading-day period and a stockholders’ deficit. As of June 11, 2024, NeueHealth's average market capitalization was approximately $49.7 million. The company's preferred stock, valued at $920.4 million as of March 31, 2024, is excluded from this calculation. The company's operations remain unaffected, and it has 45 days to submit a compliance plan to the NYSE. Pending NYSE's acceptance, the company has an 18-month period to regain compliance. During this period, NeueHealth will continue to trade under the symbol 'NEUE' with a '.BC' designation.
NeueHealth, Inc. reported strong Q1 '24 results with Revenue of $245.1 million, Net Income of $5.7 million, and Adjusted EBITDA of $2.5 million. They focus on consumer-centric care, provider partnerships, and consumer engagement. Revenue guidance for 2024 is around $1 billion, with expected segment revenues of $310-320 million for NeueCare and $690-700 million for NeueSolutions. The company aims for an Adjusted EBITDA of $15-25 million in 2024.
FAQ
What is the market cap of NeueHealth (BHG)?
What services does NeueHealth, Inc. offer?
Where is NeueHealth, Inc. currently available?
What is the mission of NeueHealth, Inc.?
What recent achievements has NeueHealth, Inc. made?
Who can benefit from NeueHealth, Inc.'s services?
How does NeueHealth, Inc. ensure a connected healthcare experience?
What are the long-term goals of NeueHealth, Inc?
How does NeueHealth, Inc. keep stakeholders informed?
What sets NeueHealth, Inc. apart from other health insurance providers?